CP-690,550
A3921069
Phase 3 small_molecule completed
Quick answer
CP-690,550 for Arthritis, Rheumatoid is a Phase 3 program (small_molecule) at Pfizer with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Arthritis, Rheumatoid
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed